Udemy
    •  
    •  
    •  
    •  
    •  
    •  
    •  
    •  
Turn what you know into an opportunity and reach millions around the world.
Learn More
Your cart is empty.
Keep shopping
Basic Course in Drug Regulatory Affairs
Rating: 4.3 out of 5(15 ratings)
44 students

Basic Course in Drug Regulatory Affairs

Introduction to Drug Regulatory Affairs Overview of Regulatory Authorities and their Functions
Created byDr Pravin Badhe
Last updated 5/2023
English
English [Auto],

What you'll learn

  • Understand the regulatory framework for drug development and approval
  • Understand the drug development process, including preclinical and clinical studies
  • Prepare regulatory submissions, including Investigational New Drug (IND) and New Drug Application (NDA) filings
  • Understand the role of regulatory agencies in drug approval

Course content

7 sections26 lectures1h 26m total length
  • Definition and scope of regulatory affairs3:19
  • Historical perspective and importance3:36
  • Roles and responsibilities of regulatory professionals3:34
  • Career opportunities in regulatory affairs3:39

Requirements

  • There are no specific requirements or prerequisites for taking this course. Learners from diverse backgrounds, including students, professionals, and anyone interested in drug regulatory affairs, are welcome to enroll in the course. That being said, a basic understanding of the pharmaceutical industry, drug development process, and the role of regulatory affairs in drug development and approval would be helpful for learners. Additionally, familiarity with scientific terminology and knowledge of basic statistical concepts will be beneficial, although not mandatory. Learners should have access to a computer and a reliable internet connection to participate in online course materials and discussions. It is also recommended that learners have access to a printer to print out relevant course materials and regulatory guidelines for reference. Overall, this course is designed to be accessible to anyone interested in the drug regulatory affairs field, and learners of all backgrounds and experience levels are encouraged to enroll and participate in this course.

Description

This course is intended to provide students with a comprehensive overview of the drug regulatory affairs field. The regulatory environment for drug development and approval is complex and highly regulated, and it is essential for those working in the pharmaceutical industry to understand the key principles and requirements.

Throughout the course, students will learn about the regulatory framework for drug development, including the various phases of the drug development process, from preclinical studies to clinical trials, and the importance of good clinical practice. They will also gain a thorough understanding of regulatory submissions, including the new drug application (NDA) and abbreviated new drug application (ANDA), as well as the importance of regulatory strategies for pharmaceutical products.

In addition to regulatory submissions, the course will cover post-approval requirements and lifecycle management, including quality assurance and good manufacturing practices (GMP), pharmacovigilance and drug safety, and compliance and inspections in drug regulatory affairs. Students will also learn about the various regulatory agencies involved in drug approval, such as the Food and Drug Administration (FDA), and the guidelines and regulations they follow.

Finally, the course will explore global regulatory affairs and harmonization and the future trends and challenges in drug regulatory affairs. By the end of the course, students will have gained a comprehensive understanding of the drug regulatory affairs field and will be well-equipped to navigate the complex regulatory environment of drug development and approval.

Who this course is for:

  • This course is intended for a wide range of learners interested in the drug regulatory affairs field. Professionals in the pharmaceutical industry, including regulatory affairs professionals, quality assurance professionals, clinical research associates, and drug safety specialists, will find the course content valuable in gaining a comprehensive understanding of the regulatory environment for drug development and approval. In addition to industry professionals, students studying pharmaceutical sciences, clinical research, pharmacology, or related fields will find the course content beneficial in understanding the regulatory requirements and guidelines that govern drug development and approval. The course will also be useful for those seeking a career in regulatory affairs and wish to learn more about the field. Finally, anyone with an interest in the pharmaceutical industry and the regulatory environment governing drug development and approval will find this course informative and valuable. This includes patients, patient advocates, and caregivers who want to learn more about the drug development process and the regulatory safeguards in place to ensure drug safety and efficacy. Overall, this course is designed to be accessible to learners with diverse backgrounds and experience levels. Learners who complete this course will gain a thorough understanding of the drug regulatory affairs field, and be well-equipped to navigate the complex regulatory environment of drug development and approval.